Axis securities's research report on PersistentPersistent kicked-offH2FY16 on a strong note with 8% QoQ revenue growth led by Enterprise segment (29% of rev, 16% QoQ growth). In EDT^, Financial Services and Healthcare continue to be key growth verticals. IP business (20% of rev) recorded strong growth of 34% QoQon equal contribution from organic business and Aepona acquisition.H2 seen better, margin upsides persist: Management expects H2 to be better than H1, driven by healthy deal pipeline and deal wins. While investments in S&M and leadership roles will increase, we believe current PBT margin of ~17% has upside potential from improvement in Aepona profitability (~3% annualized revenue share), absence of integration costs (50 bps) which were absorbed in Q3, better utilization and scale from IP/ EDT revenue. We expect USD revenue CAGR of 14%(FY14-16E: 12%) over FY16-18. In INR terms, we forecast revenue/PAT CAGR of 16%/ 19% led by PBT margin expansion of ~100 bps. Our TP ofRs700(15x FY17E EPS) implies 15% upside from CMP of Rs608; maintain BUY. The stock trades at 17x/13x FY16E/FY17E EPS.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.